Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
60.98
-0.99 (-1.60%)
At close: May 22, 2026, 4:00 PM EDT
61.07
+0.09 (0.15%)
After-hours: May 22, 2026, 7:50 PM EDT
Liquidia Market Cap
Liquidia has a market cap or net worth of $5.42 billion as of May 22, 2026. Its market cap has increased by 313.27% in one year.
Market Cap
5.42B
Enterprise Value
5.38B
1-Year Change
313.27%
Ranking
Category
Stock Price
$60.98
Market Cap Chart
Since July 26, 2018, Liquidia's market cap has increased from $167.77M to $5.42B, an increase of 3,132.22%. That is a compound annual growth rate of 55.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 5.42B | 80.73% |
| Dec 31, 2025 | 3.00B | 201.46% |
| Dec 31, 2024 | 995.33M | 20.97% |
| Dec 29, 2023 | 822.82M | 100.28% |
| Dec 30, 2022 | 410.83M | 62.30% |
| Dec 31, 2021 | 253.13M | 98.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regencell Bioscience Holdings | 13.60B |
| Dr. Reddy's Laboratories | 11.39B |
| Elanco Animal Health | 10.65B |
| Alkermes | 6.16B |
| Lantheus Holdings | 6.15B |
| Hims & Hers Health | 5.56B |
| Kiniksa Pharmaceuticals International, | 4.13B |
| Amneal Pharmaceuticals | 3.96B |